Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapy.

MLA

Korpi-Steiner, Nichole L., et al. “Liquid Chromatography-Tandem Mass Spectrometry Analysis of Urinary Fluticasone Propionate-17beta-Carboxylic Acid for Monitoring Compliance with Inhaled-Fluticasone Propionate Therapy.” Steroids, vol. 75, no. 1, Jan. 2010, pp. 77–82. EBSCOhost, https://doi.org/10.1016/j.steroids.2009.10.009.

APA

Korpi-Steiner, N. L., Netzel, B. C., Seegmiller, J. C., Hagan, J. B., & Singh, R. J. (2010). Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapy. Steroids, 75(1), 77–82. https://doi.org/10.1016/j.steroids.2009.10.009

Chicago

Korpi-Steiner, Nichole L, Brian C Netzel, Jesse C Seegmiller, John B Hagan, and Ravinder J Singh. 2010. “Liquid Chromatography-Tandem Mass Spectrometry Analysis of Urinary Fluticasone Propionate-17beta-Carboxylic Acid for Monitoring Compliance with Inhaled-Fluticasone Propionate Therapy.” Steroids 75 (1): 77–82. doi:10.1016/j.steroids.2009.10.009.